Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1172 ARTÍCULOS , VIENDO DEL 1021 AL 1035

SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study

Maher-Edwards G, Dixon R, Hunter J, Gold M, Hopton G, Jacobs G, Hunter J, Williams P.

Int J Geriatr Psychiatry. 2011 May;26(5):536-44. doi: 10.1002/gps.2562. Epub 2010 Sep 24.

Treatment of sleep disturbance in Alzheimer's dementia

Salami O, Lyketsos C, Rao V.

Int J Geriatr Psychiatry. 2011 Aug;26(8):771-82. doi: 10.1002/gps.2609. Epub 2010 Sep 24.

JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities

Mehan S, Meena H, Sharma D, Sankhla R.

J Mol Neurosci. 2011 Mar;43(3):376-90. doi: 10.1007/s12031-010-9454-6. Epub 2010 Sep 28.

Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease

Parnetti L, Chiasserini D, Andreasson U, Ohlson M, Hüls C, Zetterberg H, Minthon L, Wallin AK, Andreasen N, Talesa VN, Blennow K.

Acta Neurol Scand. 2011 Aug;124(2):122-9. doi: 10.1111/j.1600-0404.2010.01435.x. Epub 2010 Sep 29.

Physical exercise alleviates debilities of normal aging and Alzheimer's disease

Archer T.

Acta Neurol Scand. 2011 Apr;123(4):221-38. doi: 10.1111/j.1600-0404.2010.01412.x. Epub 2010 Sep 29.

Zebrafish as a tool in Alzheimer's disease research

Newman M, Verdile G, Martins RN, Lardelli M.

Biochim Biophys Acta. 2011 Mar;1812(3):346-52. doi: 10.1016/j.bbadis.2010.09.012. Epub 2010 Oct 12.

Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease

Butterfield DA, Reed T, Sultana R.

Free Radic Res. 2011 Jan;45(1):59-72. doi: 10.3109/10715762.2010.520014. Epub 2010 Oct 13.

Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease

Camandola S, Mattson MP.

Biochim Biophys Acta. 2011 May;1813(5):965-73. doi: 10.1016/j.bbamcr.2010.10.005. Epub 2010 Oct 13.

Prescription of lipophilic statins to Alzheimer's disease patients: some controversies to consider

Biondi E.

Neurol Sci. 2011 Apr;32(2):195-201. doi: 10.1007/s10072-010-0440-0. Epub 2010 Oct 19.

Anti-TNF-α reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains

Shi JQ, Shen W, Chen J, Wang BR, Zhong LL, Zhu YW, Zhu HQ, Zhang QQ, Zhang YD, Xu J.

Brain Res. 2011 Jan 12;1368:239-47. doi: 10.1016/j.brainres.2010.10.053. Epub 2010 Oct 21.

Brain fuel metabolism, aging, and Alzheimer's disease

Cunnane S, Nugent S, Roy M, Courchesne-Loyer A, Croteau E, Tremblay S, Castellano A, Pifferi F, Bocti C, Paquet N, Begdouri H, Bentourkia M, Turcotte E, Allard M, Barberger-Gateau P, Fulop T, Rapoport SI.

Nutrition. 2011 Jan;27(1):3-20. doi: 10.1016/j.nut.2010.07.021. Epub 2010 Oct 29.

α-secretase in Alzheimer's disease: molecular identity, regulation and therapeutic potential

Lichtenthaler SF.

J Neurochem. 2011 Jan;116(1):10-21. doi: 10.1111/j.1471-4159.2010.07081.x. Epub 2010 Dec 2.

Switching cholinesterase inhibitors in older adults with dementia

Massoud F, Desmarais JE, Gauthier S.

Int Psychogeriatr. 2011 Apr;23(3):372-8. doi: 10.1017/S1041610210001985. Epub 2010 Nov 3.

Clinical and economic characteristics associated with direct costs of Alzheimer's, frontotemporal and vascular dementia in Argentina

Rojas G, Bartoloni L, Dillon C, Serrano CM, Iturry M, Allegri RF.

Int Psychogeriatr. 2011 May;23(4):554-61. doi: 10.1017/S1041610210002012. Epub 2010 Nov 3.

In-vivo histamine H3 receptor antagonism activates cellular signaling suggestive of symptomatic and disease modifying efficacy in Alzheimer's disease

Bitner RS, Markosyan S, Nikkel AL, Brioni JD.

Neuropharmacology. 2011 Feb-Mar;60(2-3):460-6. doi: 10.1016/j.neuropharm.2010.10.026. Epub 2010 Oct 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias